EX-99.A 5 ck0001669811-ex99_a.htm EX-99.A

EX-99.A

Schedule A

Executive Officers and Directors of Sarepta Therapeutics, Inc.

Name		Citizenship		Position / Principal Occupation	Principal Business Address
Douglas S. Ingram		United States		President and Chief Executive Officer	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Ian M. Estepan		United States		Executive Vice President, Chief Financial Officer	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Cristin Rothfuss		United States		Executive Vice President, Chief General Counsel	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Bilal Arif		United States		Executive Vice President, Chief Technical Operations Officer	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Louise Rodino-Klapac, Ph.D.		United States		Executive Vice President, Head of R&D, Chief Scientific Officer	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Dallan Murray		United States		Executive Vice President, Chief Customer Officer	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Richard J. Barry		United States		Director Chief Executive Officer of Cassava Sciences, Inc.	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
M. Kathleen Behrens, Ph.D.		United States		Chairwoman	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Kathryn Boor, Ph.D.		United States		Director Dean of Cornell University Graduate School and Vice Provost for Graduate Education	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Michael Chambers		United States		Director	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Deirdre Connelly		United States		Director	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Stephen L. Mayo, Ph.D.		United States		Director Bren Professor of Biology and Chemistry and Merkin Institute Professor at California Institute of Technology	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Claude Nicaise, M.D.		Belgium		Director Owner, Clinical Regulatory Services	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142

DOCPROPERTY DOCXDOCID DMS=IManage Format=<<NUM>>_<<VER>> \* MERGEFORMAT 150442689_1

Hans Wigzell, M.D., Ph.D. Sweden Director Chairman of Rhenman & Partners Asset Management AB c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142

-2-

DOCPROPERTY DOCXDOCID DMS=IManage Format=<<NUM>>_<<VER>> \* MERGEFORMAT 150442689_1

Executive Officers and Directors of Sarepta Investments, Inc.

Name		Citizenship		Position / Principal Occupation	Principal Business Address
Joseph Bratica		United States		President Director	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Peter Walsh		United States		Secretary Director	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Ryan Wong		United States		Treasurer	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142
Joseph Zenkus		United States		Director	c/o Sarepta Therapeutics, Inc., 215 First Street, Suite 415, Cambridge, MA 02142

-3-

DOCPROPERTY DOCXDOCID DMS=IManage Format=<<NUM>>_<<VER>> \* MERGEFORMAT 150442689_1